Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00587028 · ClinicalTrials.gov registry record

Cathartic-Free DECT Colonography for Detection of Colonic Polyps

A clinical trial, sponsored by Mayo Clinic.

Terminated
Registry status
12
Enrollment target

NCT00587028: Clinical Trial study, sponsored by Mayo Clinic.

NCT00587028 is a clinical trial that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00587028 was terminated before completion, sponsored by Mayo Clinic.

TERMINATED
Registry status
12 participants
Enrollment target

Study Summary

Asses the clinical performance of dual-energy CTC for the detection of larger polyps 1 cm or larger without cathartic preparation.

Primary Outcome

Detection of polyps in cathartic-free CTC using optimized dual-energy techniques.

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2007-02
Est. Completion 2008-12
Mayo Clinic

2,844 total trials

Why NCT00587028 stopped before completion

NCT00587028 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 12 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT00587028 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00587028 about?

NCT00587028 is a clinical study titled "Cathartic-Free DECT Colonography for Detection of Colonic Polyps". Asses the clinical performance of dual-energy CTC for the detection of larger polyps 1 cm or larger without cathartic preparation.

What is the current status of trial NCT00587028?

This trial is currently terminated. The enrollment target is 12 participants. The study started on 2007-02. Estimated completion is 2008-12.

Who is sponsoring clinical trial NCT00587028?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02602769 · 12 participants

    Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome

  • NCT02605421 · 12 participants · Phase 2

    Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

  • NCT02619448 · 12 participants · Early Phase 1

    Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

  • NCT03311503 · 12 participants · Phase 1

    Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00587028, the US trial registry maintained by the National Library of Medicine. NCT00587028 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.